Plné znění - 390/2016 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2017

390/2016 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

390

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxxx

xx xxx 28. xxxxxxxxx 2016

x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2017

 

Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. e) zákona x. 258/2000 Sb., x ochraně xxxxxxxxx xxxxxx a x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx doporučení Xxxxxxx xxxxxxxxxx komise xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2017:

1. Antiqenní xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx

1x) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx B, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (DTaPHibVHBIPV):

Diphtheriae xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)

Xxxxxx xxxxxxxxxx1 xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)

Xxxxxxxx Bordetelly xxxxxxxxx:

Xxxxxxxxx xxxxxxxxxx1 25 xxxxxxxxxx

Xxxxxxxxxxxxxxxx xxxxxxxxxxxx1 25 mikrogramů

Pertactinum1 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxx (xxxxxxxxxxxx)

xxxxx 1 (xxxx Mahoney)4 40 D xxxxxxxx xxxxxxxx

xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (xxxx Saukett)4 32 X xxxxxxxx xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx typus b xxxxxxxxxxxxxxx 10 xxxxxxxxxx

(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3

xxxxxxxxx cum tetani xxxxxxxxxx xxxx xxxxxx xxxxxxxxx přibližně 25 xxxxxxxxxx

XXXX

1xx) kombinovaná očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (DTaPHibVHBIPV)

Diphtheriae xxxxxxxxxx xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX)2

Xxxxxx xxxxxxxxxx ne xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)2

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx

Xxxxxxxxxxxxxx filamentosum 25 mikrogramů

Virus Poliomyelitidis (xxxxxxxxxxxx)3

xxxxx 1 (Xxxxxxx) 40 D jednotek xxxxxxxx4

xxxxx 2 (MEF-1) 8 X xxxxxxxx xxxxxxxx4

xxxxx 3 (Saukett) 32 D xxxxxxxx xxxxxxxx4

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X5 10 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx xxxx b xxxxxxxxxxxxxxx 12 mikrogramů

(Polyribosylribitoli xxxxxxxx)

xxxxxxxxx xxx tetani xxxxxxxxxx 22-36 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx (XXxX):

Xxxxxxxxxxx xxxxxxxxxx ³ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx ³ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx anatoxinum (XX) 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) 25 mikrogramů

Pertactinum (69xX) 8 xxxxxxxxxx

XXXX

1xx) Očkovací xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx)

1 dávka (0,5 xx) xxxxxxxx: Xxxxxxxxxxx xxxxxxxxxx	Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxx xxxxxxxxxx	Xxxxxxxxx 20 XX* (5 Lf)
Pertusové xxxxxxxx
Xxxxxxxxx xxxxxxxxxx	2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx	5 xxxxxxxxxx
Xxxxxxxxxxx	3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3	5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx	1,5 xx (0,33 xx xxxxxxx)

XXXX

1xx) Očkovací xxxxx xxxxx xxxxxxx, xxxxxx x dávivému xxxxx (xxxxxxxxxx xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (IU) (2,5 Xx)

Xxxxxx xxxxxxxxxx1 xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)

Xxxxxxxxxxx xxxxxxxxx antigena:

Pertussis xxxxxxxxxx1 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxx externae proteinum1 2,5 xxxxxxxxxx

1 adsorbováno xx hydratovaný xxxxxxxx xxxxxxx (XX(XX)3) 0,3 xxxxxxxxx XX3+

x xxxxxxxxxxx xxxxxxx (AIP04) 0,2 xxxxxxxxx XX3+

1x) xxxxxxxx xxxxx proti záškrtu, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):

Xxxxxxxxxxx anatoxinum	min. 30 mezinárodních jednotek
Tetani xxxxxxxxxx	xxx. 40 mezinárodních xxxxxxxx
Xxxxxxxxx anatoxinum (XX)	25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx	(XXX) 25 mikrogramů
Pertactinum (69xX)	8 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx B	10 xxxxxxxxxx
xxx xxxxxxxxx xxxxxxxx	20-40 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx influenzae typ x:

1 xxxxx lyofilizované xxxxxxx obsahuje: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx xxxxx xxxxxx:

Xxxxxx xxxxxxxxxx … xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xx 16 xxx x xxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis X

20 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X v xxxxxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B

10 mikrogramů

1h) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:

Xxxxxxxxxxx virus xxxxxxxxxx (Xxxxxxx) xxx. 10^3,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx₅₀ Parotitidis xxxxx xxxxxxxxxx (XXX 4385) xxx. 10^3,7 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx₅₀ Xxxxxxxx xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 10^3,0 infekční dávka xxx buněčnou xxxxxxx₅₀

1xx) xxxxxxxx látka xxxxx xxxxxx přenosné obrně x xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx inactivatum typus 1 (Mahoney) … 40 antigenních D xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 2 (MEF-1) … 8 antigenních X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) … 32 xxxxxxxxxxx D xxxxxxxx*

* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx stanovené xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.

1x) xxxxxxxx látka xxxxx xxxxxxx xxxxxxxxx Streptococcus xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11X, 12X, 14, 15B, 17X,

18X, 19X, 19X, 20, 22F, 23F, 33X … 25 xxxxxxxxxx x xxxxxxx xxxxxxxx

1x) očkovací xxxxx xxxxxxxxxxx proti xxxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3

Xxxxxxxxxxxxx polysaccharidum sérotypus 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18X

Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X

1x) očkovací xxxxx xxxxx záškrtu, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (inaktivovaná forma):

Xxxxxxxxxxx anatoxinum	ne xxxx xxx 2 mezinárodní xxxxxxxx
Xxxxxx anatoxinum	ne méně xxx 20 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx antigeny:
Pertussis xxxxxxxxxx	8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx	8 xxxxxxxxxx
Xxxxxxxxx	2,5 xxxxxxxxxx
Xxxxx poliomyelitidis xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx)	40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)	8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)	2 X xxxxxxxx xxxxxxxx

XXXX

1x) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx	xxxx xxxx xxxxx 2 xxxxxxxxxxx jednotky (2 Lf)
Tetanický xxxxxx	xxxx xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)
Xxxxxxxxx xxxxxxxx:
&xxxx;&xxxx; Pertusový xxxxxx	2,5 mikrogramu
Xxxxxxxxxxxx xxxxxxxxxxxx	5 mikrogramů
Fimbrie xxxx 2+3	5 xxxxxxxxxx
&xxxx;&xxxx; Xxxxxxxxx	3 mikrogramy
Virus poliomyelitis xxxx 1 (xxxxxxxxxxxx)	40 xxxxxxxxxxx X xxxxxxxx
Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx)	8 antigenních X xxxxxxxx
Xxxxx poliomyelitis typu 3 (xxxxxxxxxxxx)	32 antigenních X xxxxxxxx

1x) očkovací xxxxx xxxxx tuberkulóze (XXX vakcína)

1n) očkovací xxxxx proti virové xxxxxxxxxx X xxx xxxxx zařazené do xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 mikrogramů; adjuvans XX04X obsahující 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx v 1 xxxxx

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxx xxxxxxxx

2x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:

Antigenum xxxxxxxxx xxxxxxxxxxx X

20 xxxxxxxxxx

2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx

2x) očkovací xxxxx proti virové xxxxxxxxxx A ve xxxxxxx xxx dospělé:

Hepatitis X virus xxxxxxxxxxx

3. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx

3x) xxxxxxxx látka xxxxx virové xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:

Xxxxxxxxx A xxxxx inactivatum

3b) očkovací xxxxx proti xxxxxx xxxxxxxxxx X ve xxxxxxx xxx děti:

Virus xxxxxxxxx A xxxxxxxxxxx

X xxxx 2017 x xxxxxxx na xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x očkování proti xxxxxxxxx nemocem, xx xxxxx pozdějších xxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxxx složení xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xx Xxxxxx xxxxxx.

 

Xxxxxxx:

XXXx. Xxxxxxx, MBA, x. x.

Xxxxxxxxx

Xxxxxx xxxxxxx x. 390/2016 Sb. xxxxx xxxxxxxxx xxxx 17.12.2016.

Xx xxx xxxxxxxx právní xxxxxxx nebyl xxxxx xx xxxxxxxxx.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx aktualizováno, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.